Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Neuropace Inc | NPCE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 12.99 | 04:05:14 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.99 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 3.795 - 18.15 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 12.99 | USD |
Neuropace Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 368.2M | 28.34M | - | 65.42M | -32.96M | -1.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Neuropace News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NPCE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 13.78 | 14.505 | 12.96 | 13.88 | 90,371 | -0.79 | -5.73% |
| 1 Month | 13.40 | 15.7747 | 12.10 | 13.75 | 145,784 | -0.41 | -3.06% |
| 3 Months | 15.55 | 18.15 | 12.10 | 14.31 | 108,473 | -2.56 | -16.46% |
| 6 Months | 6.37 | 18.15 | 6.08 | 12.44 | 93,893 | 6.62 | 103.92% |
| 1 Year | 4.36 | 18.15 | 3.795 | 10.37 | 70,497 | 8.63 | 197.94% |
| 3 Years | 25.59 | 27.38 | 1.22 | 11.00 | 68,002 | -12.60 | -49.24% |
| 5 Years | 23.25 | 27.38 | 1.22 | 11.95 | 72,754 | -10.26 | -44.13% |
Neuropace Description
| NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System. |
